Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,415 | 1,337 | 99.8% |
| Education | $53.47 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,895 | 190 | $0 (2024) |
| Amarin Pharma Inc. | $2,455 | 132 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,251 | 129 | $0 (2024) |
| PFIZER INC. | $1,570 | 115 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,481 | 91 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,373 | 73 | $0 (2024) |
| Amgen Inc. | $1,183 | 65 | $0 (2024) |
| ABBVIE INC. | $1,076 | 65 | $0 (2024) |
| Lilly USA, LLC | $1,057 | 78 | $0 (2024) |
| Astellas Pharma US Inc | $495.30 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,418 | 113 | Novo Nordisk Inc ($294.91) |
| 2023 | $2,505 | 132 | AbbVie Inc. ($395.66) |
| 2022 | $2,729 | 153 | Amgen Inc. ($391.90) |
| 2021 | $3,385 | 203 | Amarin Pharma Inc. ($622.50) |
| 2020 | $2,956 | 178 | Amarin Pharma Inc. ($635.86) |
| 2019 | $2,993 | 181 | Novo Nordisk Inc ($482.54) |
| 2018 | $3,628 | 209 | Novo Nordisk Inc ($897.43) |
| 2017 | $2,854 | 177 | Novo Nordisk Inc ($958.35) |
All Payment Transactions
1,346 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: OUD | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $9.53 | General |
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $79.96 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.63 | General |
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $19.52 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oncology | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: DIABETES | ||||||
| 10/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.37 | General |
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,749 | 4,620 | $816,056 | $240,633 |
| 2022 | 25 | 2,324 | 3,945 | $690,712 | $226,325 |
| 2021 | 28 | 2,378 | 4,371 | $698,509 | $260,550 |
| 2020 | 32 | 2,518 | 4,415 | $659,664 | $244,705 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 482 | 1,488 | $476,160 | $121,819 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 306 | 306 | $99,756 | $38,848 | 38.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 247 | 247 | $52,611 | $19,651 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 259 | $59,052 | $16,025 | 27.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 47 | 55 | $23,045 | $6,101 | 26.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 321 | 628 | $10,399 | $5,237 | 50.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 259 | 259 | $12,173 | $4,623 | 38.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 253 | 253 | $11,638 | $4,516 | 38.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $11,360 | $4,478 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 29 | $13,166 | $3,313 | 25.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $6,560 | $2,733 | 41.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 38 | 42 | $3,276 | $2,233 | 68.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 30 | 35 | $5,880 | $1,791 | 30.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 71 | 166 | $5,976 | $1,702 | 28.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 54 | 54 | $3,618 | $1,385 | 38.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $3,034 | $1,210 | 39.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 48 | 54 | $4,536 | $1,172 | 25.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 26 | 205 | $3,485 | $1,024 | 29.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 16 | $2,656 | $741.48 | 27.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $1,716 | $530.92 | 30.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $1,258 | $514.08 | 40.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 37 | $2,553 | $324.15 | 12.7% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 29 | 34 | $476.00 | $144.00 | 30.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 49 | 63 | $378.00 | $138.60 | 36.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 28 | 28 | $308.00 | $120.12 | 39.0% |
About Thomas Taylor, M. D
Thomas Taylor, M. D is a Family Medicine healthcare provider based in Yulee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700866621.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Taylor, M. D has received a total of $23,468 in payments from pharmaceutical and medical device companies, with $2,418 received in 2024. These payments were reported across 1,346 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($23,415).
As a Medicare-enrolled provider, Taylor has provided services to 9,969 Medicare beneficiaries, totaling 17,351 services with total Medicare billing of $972,213. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Yulee, FL
- Active Since 01/18/2006
- Last Updated 12/12/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700866621
Products in Payments
- Vascepa (Drug) $2,455
- Ozempic (Drug) $1,461
- FARXIGA (Drug) $1,243
- JARDIANCE (Drug) $1,050
- TRELEGY ELLIPTA (Drug) $838.75
- Victoza (Drug) $734.42
- CHANTIX (Drug) $590.61
- VRAYLAR (Drug) $476.73
- XARELTO (Drug) $423.91
- Dexcom G6 Transmitter (Medical Supply) $421.82
- SYMBICORT (Drug) $388.89
- Tresiba (Drug) $373.07
- UBRELVY (Drug) $365.82
- Rybelsus (Drug) $358.89
- MOUNJARO (Drug) $353.35
- Aimovig (Biological) $335.52
- Dayvigo (Drug) $328.21
- Repatha (Biological) $327.34
- Otezla (Drug) $321.24
- MYRBETRIQ (Drug) $305.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Yulee
David White, Md, MD
Family Medicine — Payments: $22,446
Dr. Chisara Adonai, Md, MD
Family Medicine — Payments: $5,229
Dr. Obaidullah Ahmed, Md, MD
Family Medicine — Payments: $4,071
Dr. Erica Wiedl, Md, MD
Family Medicine — Payments: $534.03
Dr. Jeremy Coleman, M.d, M.D
Family Medicine — Payments: $122.87
Martha Mcdonough, D.o, D.O
Family Medicine — Payments: $41.96